Get access

Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations

Authors

  • Susanne A. Schneider MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    Search for more papers by this author
  • Penelope Talelli MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    Search for more papers by this author
  • Binith J. Cheeran MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    Search for more papers by this author
  • Naheed L. Khan MD,

    1. Department of Molecular Neuroscience, Institute of Neurology, UCL, Queen Square, London, United Kingdom
    Search for more papers by this author
  • Nicholas W. Wood MD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    Search for more papers by this author
  • John C. Rothwell PhD,

    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    Search for more papers by this author
  • Kailash P. Bhatia MD

    Corresponding author
    1. Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square London, United Kingdom
    • Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square; London WC1N 3BG, United Kingdom
    Search for more papers by this author

  • The authors report no conflicts of interest.

Abstract

Autosomal recessive parkin (PARK2) gene-related parkinsonism may be phenotypically and pathophysiologically distinct from idiopathic Parkinson's disease (PD). Furthermore, asymptomatic subjects carrying a single parkin mutation (“parkin carriers”) may show striatal dopaminergic dysfunction and increased cortical movement-related activation. Here, we used transcranial magnetic stimulation (TMS) to study corticospinal and intracortical excitability in manifesting parkin patients and asymptomatic carriers. We studied resting and active motor thresholds (RMT/AMT), central motor conduction time (CMCT), active recruitment curves, short-interval intracortical inhibition (SICI) and facilitation (ICF), SICI recruitment curve, and cortical silent period (CSP) in 8 patients “off” medication, 7 carriers, and two groups of age-matched controls (n = 21). Patients had longer CMCTs compared to controls with a significant negative correlation between CMCT duration and onset age (r = −0.83, P = 0.04). Carriers had increased RMT/AMT; the time course of SICI/ICF and the duration of CSP were normal in both patients and carriers; however slight abnormalities in the recruitment of SICI were found in the carriers. Prolonged CMCT and normal cortical inhibitory mechanisms in parkin patients may be of value in the differentiation from idiopathic PD. The subclinical electrophysiological abnormalities found in carriers may represent underlying compensatory mechanisms. © 2008 Movement Disorder Society

Ancillary